Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin against Drug-Resistant Ovarian Cancer Cells

Angewandte Chemie - International Edition

Volumn 54, Issue 45, 2015, Pages 13307-13311

  Li, Jie ^a   Kuang, Yi ^a   Shi, Junfeng ^a   Zhou, Jie ^a   Medina, Jamie E ^b   Zhou, Rong ^a   Yuan, Dan ^a   Yang, Cuihong ^d   Wang, Huaimin ^c   Yang, Zhimou ^c   Liu, Jianfeng ^d   Dinulescu, Daniela M ^b   Xu, Bing ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NANKAI UNIVERSITY   (China)

^d INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

cisplatin; combination therapy; drug resistance; enzymes; self assembly

Indexed keywords

CYTOLOGY; DISEASES; DRUG INTERACTIONS; DRUG THERAPY; ENZYMES; PEPTIDES; PLATINUM COMPOUNDS; SELF ASSEMBLY;

CIS-PLATIN; COMBINATION THERAPY; DRUG RESISTANCE; INNOVATIVE APPROACHES; MOLECULAR SELF ASSEMBLY; OPTIMAL CONCENTRATION; OVARIAN CANCER CELLS; SUPRAMOLECULAR ASSEMBLIES;

CELLS;

ANTINEOPLASTIC AGENT; CARBOXYLESTERASE; CISPLATIN; PEPTIDE;

CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARBOXYLESTERASE; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MOLECULAR STRUCTURE; OVARIAN NEOPLASMS; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84945439559     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201507157     Document Type: Article

References (62)

1. B. Rosenberg, L. Vancamp, T. Krigas, Nature 1965, 205, 698-699.
2. B. Rosenberg, L. Vancamp, J. E. Trosko, V. H. Mansour, Nature 1969, 222, 385-386;
3. B. Rosenberg, Cancer 1985, 55, 2303-2316.
4. D. K. Armstrong, B. Bundy, L. Wenzel, H. Q. Huang, R. Baergen, S. Lele, L. J. Copeland, J. L. Walker, R. A. Burger, Gynecologic Oncology Grp, 2006, 354, 34-43.
5. New Engl. J. Med.
6. T. A. Yap, C. P. Carden, S. B. Kaye, Nat. Rev. Cancer 2009, 9, 167-181;
7. D. M. Parkin, Lancet Oncol. 2001, 2, 533-543;
8. R. T. Greenlee, M. B. Hill-Harmon, T. Murray, M. Thun, CA-Cancer J. Clin. 2001, 51, 15-36;
9. C. A. Rabik, M. E. Dolan, Cancer Treat. Rev. 2007, 33, 9-23;
10. R. L. Siegel, K. D. Miller, A. Jemal, Ca-cancer J. Clin. 2015, 65, 5-29.
11. Z. M. Yang, H. W. Gu, D. G. Fu, P. Gao, J. K. Lam, B. Xu, Adv. Mater. 2004, 16, 1440-1444;
12. C. G. Pappas, I. R. Sasselli, R. V. Ulijn, Angew. Chem. Int. Ed. 2015, 54, 8119-8123;
13. Angew. Chem. 2015, 127, 8237-8241.
14. Z. Yang, G. Liang, B. Xu, Acc. Chem. Res. 2008, 41, 315-326;
15. Y. Gao, Y. Kuang, X. Du, J. Zhou, P. Chandran, F. Horkay, B. Xu, Langmuir 2013, 29, 15191-15200;
16. Y. Gao, C. Berciu, Y. Kuang, J. Shi, D. Nicastro, B. Xu, ACS Nano 2013, 7, 9055-9063;
17. Y. Gao, J. Shi, D. Yuan, B. Xu, Nat. Commun. 2012, 3, 1033;
18. Z. M. Yang, K. M. Xu, Z. F. Guo, Z. H. Guo, B. Xu, Adv. Mater. 2007, 19, 3152-3156.
19. Y. Kuang, M. J. C. Long, J. Zhou, J. Shi, Y. Gao, C. Xu, L. Hedstrom, B. Xu, J. Biol. Chem. 2014, 289, 29208-29218.
20. Y. Kuang, B. Xu, Angew. Chem. Int. Ed. 2013, 52, 6944-6948;
21. Angew. Chem. 2013, 125, 7082-7086.
22. A. Tanaka, Y. Fukuoka, Y. Morimoto, T. Honjo, D. Koda, M. Goto, T. Maruyama, J. Am. Chem. Soc. 2015, 137, 770-775.
23. R. A. Pires, Y. M. Abul-Haija, D. S. Costa, R. Novoa-Carballal, R. L. Reis, R. V. Ulijn, I. Pashkuleva, J. Am. Chem. Soc. 2015, 137, 576-579.
24. C. Yang, M. Bian, Z. Yang, Biomater. Sci. 2014, 2, 651-654;
25. H. Wang, Z. Yang, Soft Matter 2012, 8, 2344-2347.
26. J. A. Zorn, H. Wille, D. W. Wolan, J. A. Wells, J. Am. Chem. Soc. 2011, 133, 19630-19633;
27. J. P. Schneider, D. J. Pochan, B. Ozbas, K. Rajagopal, L. Pakstis, J. Kretsinger, J. Am. Chem. Soc. 2002, 124, 15030-15037;
28. C. J. Newcomb, S. Sur, J. H. Ortony, O.-S. Lee, J. B. Matson, J. Boekhoven, J. M. Yu, G. C. Schatz, S. I. Stupp, Nat. Commun. 2014, 5, 3321.
29. Y. Kuang, J. Shi, J. Li, D. Yuan, K. A. Alberti, Q. Xu, B. Xu, Angew. Chem. Int. Ed. 2014, 53, 8104-8107;
30. Angew. Chem. 2014, 126, 8242-8245.
31. S. Guichard, C. Terret, I. Hennebelle, I. Lochon, P. Chevreau, E. Fretigny, J. Selves, E. Chatelut, R. Bugat, P. Canal, Br. J. Cancer 1999, 80, 364-370;
32. S. P. Sanghani, S. K. Quinney, T. B. Fredenburg, Z. J. Sun, W. I. Davis, D. J. Murry, O. W. Cummings, D. E. Seitz, W. F. Bosron, Clin. Cancer Res. 2003, 9, 4983-4991;
33. Y. Xu, M. A. Villalona-Calero, Ann. Oncol. 2002, 13, 1841-1851;
34. K. Ohtsuka, S. Inoue, M. Kameyama, A. Kanetoshi, T. Fujimoto, K. Takaoka, Y. Araya, A. Shida, Lung Cancer 2003, 41, 187-198;
35. V. J. Stella, R. T. Borchardt, M. J. Hageman, R. Oliyai, H. Maag, J. W. Tilley, Prodrugs: Challenges and Rewards, Springer, New York, 2007.
36. C. B. He, K. D. Lu, D. M. Liu, W. B. Lin, J. Am. Chem. Soc. 2014, 136, 5181-5184.
37. Y. Zhang, Y. Kuang, Y. A. Gao, B. Xu, Langmuir 2011, 27, 529-537.
38. J. Boekhoven, M. Koot, T. A. Wezendonk, R. Eelkema, J. H. van Esch, J. Am. Chem. Soc. 2012, 134, 12908-12911;
39. M. Yamanaka, M. Kawaharada, Y. Nito, H. Takaya, K. Kobayashi, J. Am. Chem. Soc. 2011, 133, 16650-16656;
40. M. He, J. Li, S. Tan, R. Wang, Y. Zhang, J. Am. Chem. Soc. 2013, 135, 18718-18721;
41. A. G. Cheetham, P. Zhang, Y.-a. Lin, L. L. Lock, H. Cui, J. Am. Chem. Soc. 2013, 135, 2907-2910;
42. B. A. Rosenzweig, N. T. Ross, M. J. Adler, A. D. Hamilton, J. Am. Chem. Soc. 2010, 132, 6749-6754;
43. D. J. Pochan, J. P. Schneider, J. Kretsinger, B. Ozbas, K. Rajagopal, L. Haines, J. Am. Chem. Soc. 2003, 125, 11802-11803;
44. K. J. Nagy, M. C. Giano, A. Jin, D. J. Pochan, J. P. Schneider, J. Am. Chem. Soc. 2011, 133, 14975-14977;
45. T. Yoshii, K. Mizusawa, Y. Takaoka, I. Hamachi, J. Am. Chem. Soc. 2014, 136, 16635-16642;
46. R. T. Woodward, L. A. Stevens, R. Dawson, M. Vijayaraghavan, T. Hasell, I. P. Silverwood, A. V. Ewing, T. Ratvijitvech, J. D. Exley, S. Y. Chong, F. Blanc, D. J. Adams, S. G. Kazarian, C. E. Snape, T. C. Drage, A. I. Cooper, J. Am. Chem. Soc. 2014, 136, 9028-9035;
47. W. Deng, H. Yamaguchi, Y. Takashima, A. Harada, Angew. Chem. Int. Ed. 2007, 46, 5144-5147;
48. Angew. Chem. 2007, 119, 5236-5239;
49. Z. Shen, T. Wang, M. Liu, Angew. Chem. Int. Ed. 2014, 53, 13424-13428;
50. Angew. Chem. 2014, 126, 13642-13646;
51. S. Singh, F. Topuz, K. Hahn, K. Albrecht, J. Groll, Angew. Chem. Int. Ed. 2013, 52, 3000-3003;
52. Angew. Chem. 2013, 125, 3074-3077;
53. C. Maity, W. E. Hendriksen, J. H. van Esch, R. Eelkema, Angew. Chem. Int. Ed. 2015, 54, 998-1001;
54. Angew. Chem. 2015, 127, 1012-1015;
55. S. Tamesue, Y. Takashima, H. Yamaguchi, S. Shinkai, A. Harada, Angew. Chem. Int. Ed. 2010, 49, 7461-7464;
56. Angew. Chem. 2010, 122, 7623-7626;
57. T. W. Liu, T. D. MacDonald, J. Shi, B. C. Wilson, G. Zheng, Angew. Chem. Int. Ed. 2012, 51, 13128-13131;
58. Angew. Chem. 2012, 124, 13305-13308;
59. K. K. Carter, H. B. Rycenga, A. J. McNeil, Langmuir 2014, 30, 3522-3527.
60. H. D. Riordan, N. H. Riordan, X. L. Meng, J. Zhong, J. A. Jackson, Anticancer Res. 1994, 14, 927-931.
61. L. M. Mendonça, G. C. dos Santos, G. A. Antonucci, A. C. dos Santos, M. d. L. Pires Bianchi, L. M. Greggi Antunes, Mutat. Res. Genet. Toxicol. Environ. Mutag. 2009, 675, 29-34.
62. R. F. Ozols, B. N. Bundy, B. E. Greer, J. M. Fowler, D. Clarke-Pearson, R. A. Burger, R. S. Mannel, K. DeGeest, E. M. Hartenbach, R. Baergen, J. Clin. Oncol. 2003, 21, 3194-3200.